Summit Therapeutics Inc. (SMMT) Net Income by Year
Summit Therapeutics Inc. reported a net loss of $1.1B in fiscal year 2025. This represents a decrease of 387.8% from the prior fiscal year. The table below carries 9 fiscal years, from 2018 to 2025, and the quarters Summit Therapeutics Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SMMT Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
SMMT Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Summit Therapeutics Inc. financials
Frequently Asked Questions
What was Summit Therapeutics Inc.'s net income in fiscal year 2025?
Summit Therapeutics Inc. reported a net loss of $1.1B in fiscal year 2025.
How fast is Summit Therapeutics Inc.'s net income growing?
Summit Therapeutics Inc. (SMMT) net income fell by 387.8% year over year, from -$221.3M to -$1.1B in fiscal year 2025.
How has Summit Therapeutics Inc.'s net income changed over the years?
Across the 9 fiscal years this page covers, Summit Therapeutics Inc. (SMMT) net income went from -$26.4M in fiscal year 2018 to -$1.1B in fiscal year 2025.
What was Summit Therapeutics Inc.'s net income in the most recent quarter?
Summit Therapeutics Inc. (SMMT) reported -$215.7M in net income in Q2 2026. This represents an increase of 61.9% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Summit Therapeutics Inc. (SMMT) reported on that line in every period on record.